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New Classes of Environmental Tumor
Promoters: Indole Alkaloids and
Polyacetates
by Hirota Fujiki,* Takashi Sugimura* and
Richard E. Mooret
Tumor promoters are known to induce ODC activity in mouse skin and that this induction can be
inhibited by the application of 13-cis-retinoic acid. These two properties of tumor promoters were
utilized for screening new tumor promoters in our environment. Two new classes of tumor promo-
ters are presented: indole alkaloids (teleocidin and lyngbyatoxin A) and polyacetates (aplysiatoxin
and debromoaplysiatoxin).
Teleocidin from streptomyces and lyngbyatoxin A, from the blue-green alga, Lgngbya majuscula,
were able to induce ODC activity in mouse skin and showed various biological activities similar to
those of TPA. Teleocidin and lyngbyatoxin A are indole alkaloids. Their tumor promoting activities
became apparent in the mouse skin through a two-stage carcinogenicity test. The tumor incidence
of the group treated with DMBA plus teleocidin was 100% at week 30, which was similar to that of
the group given DMBA and TPA. The in vivo carcinogenicity test with lyngbyatoxin A is still under-
way. The tumor incidence of the group treated with DMBA plus lyngbyatoxin A is 80% at week 21.
A second new class of tumor promoter is polyacetate. Aplysiatoxin and debromoaplysiatoxin were
isolated from another variety of blue-green alga. Aplysiatoxin and debromoaplysiatoxin induce ODC
to the same degree of potency. However, aplysiatoxin induced various membrane effects, such as ad-
hesion of cells and turnover of phospholipid with a similar concentration of TPA, teleocidin and
lyngbyatoxin A. On the other hand, debromoaplysiatoxin required an amount almost 100 times
greater to achieve the same effects.
We are convinced of the possibility that various classes of tumor promoters exist in our environ-
ment.
Introduction
An extensive search for mutagens and carcino-
gens in the human environment was undertaken by
the National Cancer Center Research Institute in
Tokyo (1). Several potent mutagens and carcinogens
were found and identified for the first time in food
and in pyrolysis products of various amino acids (2).
These findings supported the proposal, made on the
basis of statistical findings, that most human
cancers are caused by environmental factors (3, 4).
With this in mind, we began screening for new
tumor promoters in the environment.
In screening for tumor promoters, we used the
following four-step test; first, a test of irritancy on
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mouse ear; second, a test on induction of ornithine
decarboxylase (ODC) activity in mouse skin; third a
test of adhesion with human promyelocytic leuke-
mia cells (HL-60); fourth, an in vivo carcinogenicity
test.
We tested about 270 compounds on mouse ear.
These compounds included various pure and impure
compounds thought to be irritants. Of these, 43
materials caused significant reddening of mouse
ear, 15 of these 43 compounds induced ODC activity
with the same potency as TPA, and five of the 15
compounds caused cell adhesion of HL-60 cells. Up
to now, three of five compounds have been proven
to be potent promoters in an in vivo carcinogenicity
test. We have now found five possible new tumor
promoters, which are related to indole alkaloids and
polyacetates. Teleocidin, dihydroteleocidin B, which
was obtained by catalytic hydrogenation of
teleocidin B and lyngbyatoxin A are indole alka-FUJIKIETAL.
loids. Aplysiatoxin and debromoaplysiatoxin are
polyacetates.
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was expressed as the percentage of tumor-bearing
mice; i.e., the number of surviving mice bearing at
least one skin tumor per number of survivors x
100 (11, 12). As a positive control, 2.5 ,g of TPA was
applied to the skin twice weekly.
Various in Vitro Biological Tests
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This paper describes the various biological activi-
ties, including in vivo tumor-promoting activities of
these five new compounds.
Methods
Irritant Test on Mouse Ear
Compounds were tested on the ear of 8-week-old
female CD-1 mice. Irritancy on mouse ear was
estimated 24 hr after administration of the com-
pounds. The ID.' value is the amount that causes
reddening of the ears of 50% of the mice (5).
Induction of ODC Activity
ODC activity was determined 4 hr after applica-
tion of the compound, to the skin of the back of 8-
week-old female CD- mice (6). The assay procedure
used was essentially that of O'Brien (7, 8). Inhibition
of ODC induction by 13-cis-retinoic acid was
examined by the procedure of Verma and Boutwell
(9).
In Vitro Test of Adhesion of HL-60 Cells
Adhesion of HL-60 cells was tested as described
elsewhere (6, 10).
In Vivo Carcinogenicity Test
Carcinogenesis was initiated with 100 Mg of
DMBA in the skin of 8-week-old female CD-1 mice.
Promotion was carried out by administration 1
week later 2.5 ,ug of teleocidin, 2.5 Mg of dihydrotele-
ocidin B or 3.0 Mg of lyngbyatoxin A twice weekly.
The numbers of tumors 1 mm or more in diameter
were counted weekly. Tumor- promoting activity
Induction of terminal differentiation of HL-60
cells is associated with increased phagocytosis (13).
Lyeoyidtin A Aggregation of human lymphoblastoid cells (NL-3)
transformed by Epstein-Barr virus was estimated
as described previously (14). Inhibition of terminal
CH, differentiation of Friend erythroleukemia cells
-4 induced by dimethyl sulfoxide was followed by
measuring benzidine-reactive cells (6, 10). Inhibition
OH of specific binding of 3H-PDBu to rat embryo
fibroblast cell monolayer cultures (FRE-8D) was
toxin observed (15). Indole alkaloids and TPA had similar
effects on other biological parameters. References
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Transplacental Initiation and Postnatal
Promotion
Initiation was carried out by intragastric intuba-
tion of 60 mg of DMBA/kg body weight into preg-
nant mice on day 10 or 17 of pregnancy (16). For
promotion, 2.5 Mg of teleocidin was applied twice
weekly to the skin of the back of the offspring from
week 8 after birth.
Materials
Teleocidin was isolated from mycelia of Strepto-
myces mediocidicus by Takashima (17). Recently we
found that teleocidin is a mixture of teleocidin A,
teleocidin B, and their isomers (18). Dihydroteleo-
cidin B was obtained by catalytic hydrogenation of
the vinyl group of teleocidin B (19). Teleocidin A has
the same chemical structure as lyngbyatoxin A (20).
Lyngbyatoxin A was isolated from a blue-green
alga, Lyngbya majuscula (21). Aplyslatoxin and
debromoaplysiatoxin, a debrominated form of
aplysiatoxin, were isolated from another variety of
blue-green alga,Lyngbya majuscula (22, 23).
Results
Irritant Test
Three indole alkaloids, teleocidin, dihydroteleoci-
din B, and lyngbyatoxin A, and two polyacetates,
aplysiatoxin and debromoaplysiatoxin, are potent
skin irritants (Table 1). The effective concentrations
of these five compounds in the irritant test were
very similar to that of TPA. The chemical struc-
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Table 1. Comparison of the effects of indole alkaloids and polyacetates with those of TPA.
Dihydro- Lyngbya- Aplysia- Debromo-
TPA Telocidin teleocidin B toxin A toxin aplysiatoxin
Irritant test
ID", nmole/eara 0.016 0.008 0.017 0.011 0.005 0.005
ODC assay
Induction, nmoles C02/5.0
,ug compoundsb 1.45 1.89 1.55 2.05 3.62c 2.97c
Inhibition by
retinoic acid, %d 81.9 70.6 78.7 65.5 89.7 74.1
Tumor-promoting activity
Maximal tumor incidence, % 100 100 90 80e
a Results are means of six animals.
b Results are means of two animals.
c Induction was estimated as the amount per 2.5jAg of compound.
d Results are means of two animals.
e Tumor incidence in week 21 is shown.
tures of these compounds are entirely different
from that of phorbol ester.
Induction of ODC Activity
The above five compounds induced ODC activity
in mouse skin. The effects of these compounds on
ODC induction were all apparently inhibited by 13-
cis-retinoic acid (Table 1). All five compounds gave
bell-shaped dose-response curves, and the doses for
maximum activity were in a narrow range, higher
doses having cytotoxic effects. However, induction
with TPA increased steadily with doses of up to 1.0
mg as previously reported (10).
In Vivo Carcinogenicity Test
The tumor incidences in groups treated with
DMBA plus teleocidin, DMBA plus dihydroteleoci-
din B and DMBA plus lyngbyatoxin A are summar-
ized in Table 1. The increases in tumor incidences in
groups treated with DMBA plus teleocidin and
DMBA plus TPA are shown in Figure 1. Both
groups showed 100% tumor incidence by week 24.
No tumors were observed in the groups treated
with teleocidin alone or with a single application of
DMBA, and only one mouse in the group treated
with TPA alone had a tumor, which was identified
histologically as a papilloma. The tumors in the two
groups were examined histologically and classified
into two types: squamous cell carcinomas and
papillomas. The percentage incidences of squamous
cell carcinomas and papillomas in the two groups
were almost identical. These results are comparable
with those on a group given DMBA plus dihydrote-
leocidin B reported previously (10, 24). Thus teleo-
cidin and dihydroteleocidin B are as effective as
TPA in the promotion ofmalignancy.
An in vivo carcinogenicity test with lyngbyatoxin
A is still underway, but the tumor incidence in the
group treated with DMBA plus lyngbyatoxin A was
80% in week 21. Carcinogenicity tests have not yet
been done on aplysiatoxin and debromoaplysiatoxin.
Various Biological Activities
The three indole alkaloids all induced both adhe-
sion and differentiation of human promyelocytic
leukemia cells (HL-60), induced aggregation of hu-
man lymphoblastoid cells (NL-3), and inhibited dif-
ferentiation of Friend erythroleukemia cells with
potencies equivalent to those of TPA. The doses of
these compounds necessary for these four activities
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FIGURE 1. Tumor incidences in mice treated with 100 ,ug
DMBA followed by 2.5 Mg teleocidin and (0) 100 Mag DMBA
followed by 2.5 Mg TPA. One animal in the group treated
with 2.5 Mg TPA alone had a tumor (A). No tumors were
observed in groups treated with 2.5 ug teleocidin alone, or
100 Mg DMBA alone (O). Results are from groups consist-
ing of 15 animals each.
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were exactly the same as those of TPA (6, 10) (Table
2).
It is interesting that various membrane effects,
such as adhesion, differentiation of HL-60 cells, and
aggregation of NL-3 cells, were induced by similar
concentrations of aplysiatoxin and TPA (25).
Since indole alkaloids are structurally unrelated
to TPA, it was of interest to determine whether
they have similar effects to TPA on cell membrane
receptors. We found that TPA, teleocidin and
lyngbyatoxin A all inhibit the specific binding of 3H-
PDBu (15, 26) (Table 2). From this finding we
conclude that these compounds may act via the
same receptor system. Recently, Huberman (27)
isolated a TPA-resistant mutant of HL-60 cells, and
found that this mutant showed both TPA resistance
and teleocidin resistance. Similar coincidence has
been observed with Friend erythroleukemia cells
(28)and nematodes (29)(Table 3).
Transplacental Initiation and Postnatal
Promotion
An experiment on transplacental initiation and
postnatal promotion was performed in mice. The
tumor incidence in the offspring of the group
treated with DMBA on day 17 of gestation with
subsequent promotion with teleocidin was 47% in
week 23. The offspring of mice treated with DMBA
on the 10th day of gestation with subsequent
promotion with teleocidin showed 10% tumor in-
cidence. Those of mice treated with teleocidin but
not DMBA did not have any tumors.
Table 2. Comparison of various biological effects of indole alkaloids and polyacetates with those of TPA.
Dihydro- Lyngbya- Aplysia- Debromo-
TPA Teleocidin teleocidin B toxin A toxin aplysiatoxin
HL-60 cells
50% adhesion, ng/ml 1.5 4.0 0.3 7.0 2.0 180
ED. of phagocytosis, ng/ml 2.5 3.6 1.4 2.5 1.7 100
Aggregation of NL-3 cells
ED50, ng/ml 11.2 3.1 6.5 2.4 2.1 180
Inhibition of differentiation of
Friend erythroleukemia cells
ED,, ng/ml 1.0 2.0 0.2 0.4 150
Inhibition of specific binding
of 3H-PDBu
ED,0 ng/ml 3.0 5.0 8 48
Table 3. Similar effects of TPA and indole alkaloid.
Effect Reference
In Vivo effect
Induction of dark keratinocytes in mouse skin (35)
Induction of hyperplasia and hyperkeratosis in mouse skin (10)
Membrane effect
Increase in 2-deoxyglucose uptake (15)
Release of arachidonic acid (15)
Formation of prostaglandins (36)
Release of choline
Inhibition of epidermal growth factor binding (15)
Production of superoxide anion radical (02-') in human polymorphonuclear leukocytes (37)
Adaptation to allosteric site in phospholipase A2 (38)
Differentiation Inhibition or Induction
Inhibition of induced melanogenesis in B16 melanoma cells (39)
Inhibition of induced myogenesis in human myoblasts (40)
Amelanotic effect and morphological change of reconstituted cells (39)
Coincidence with TPA resistance in Friend erythroleukemia cells (41)
Transformation, adenovirus and EB virus
Increase in transformed foci after treatment with chemical carcinogen (42)
Enhancement of colony formation of Adenovirus-infected lymphocytes (40)
Enhancement of colony formation of EBV-infected cord blood lymphocytes (14)
Enhancement of early antigen and viral capsid antigen production (43)
Others
Induction of abnormal movements of a nematode (Caenorhabditis elegans) (44)
Coincidence with TPA-resistance of mutants of a nematode (C. elegans) (44)
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Actions of Aplysiatoxin and
Debromoaplysiatoxin
A 100 times greater dose of debromoaplysiatoxin
was required to achieve the same effect (10, 13).
This means that bromination of the phenol groups
in the molecule of debromoaplysiatoxin greatly
enhanced the effect on the cell membrane (Table 2).
Discussion
This paper described new tumor promoters
which were detected by our four-step screening
method for tumor promoters in the environment;
i.e., an irritant test on mouse ear, a test of ODC in-
duction in mouse skin, a test of adhesion with HL-60
cells and an in vivo carcinogenicity test. The irritant
test is a sensitive and practical method as a first
screening test. It can be used for various kinds of
compounds from a wide variety of sources and does
not usually require a large amount of material. The
IDso values of newly found tumor promoters are in
the range of 5-10 ng. Since ODC induction in mouse
skin appears to be an essential phenotypic change
for tumor promotion (30), ODC assay is useful as a
second screening test. However, several compounds
were found to show similar effects to TPA in the
test of ODC induction, but were not tumor promo-
ters or were only weak promoters in mouse skin
(31-34). To distinguish these nonpromoters, we
introduced a third test on cell membrane effects,
even though the mechanistic relation between
tumor promotion and membrane phenomena needs
clarification.
Experiments on transplacental initiation in preg-
nant mice and postnatal promotion by teleocidin as
well as TPA on the skin of the back of the offspring
have opened up a new concept of tumor promotion.
It is now known that the human environment
contains a number of mutagens and carcinogens,
and it is important to find out how to protect hu-
mans from contact with these environmental tumor
promoters, since this is crucial for preventing
human cancer.
Carcinogenicity tests on aplysiatoxin and debro-
moaplysiatoxin will provide critical information on
the utility of the third test. We are certain that
various classes of tumor promoters are present in
our environment and that other tumor promoters
will be found by the four-step screening.
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